Clinical Trial Update: Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating the combination of disulfiram with copper gluconate and liposomal doxorubicin in treatment-refractory relapsed sarcomas and is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Copper gluconate (copper gluconate)
• Disulfiram (Disulfiram)
• Doxil (liposomal doxorubicin)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Relapsed Sarcomas | Phase 1 | Status: RECRUITING